CD86 and neoplasm: In different tumor mouse models, T cells expanded from OKT3-28BB/CD86/4-1BBL RNA electroporation showed anti-tumor activities superior to those of OKT3/IL-2 T cells and similar to those of CD3/CD28 Dynabead T cells.